Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus

被引:52
作者
Ruzin, A
Severin, A
Moghazeh, SL
Etienne, J
Bradford, PA
Projan, SJ
Shlaes, DM
机构
[1] Wyeth Res, Pearl River, NY 10965 USA
[2] Fac Med Laennec, INSERM E0230, Unite Pathogenie Staphylocoques, Lyon, France
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2003年 / 1621卷 / 02期
关键词
Staphylococcus aureus; vancomycin; inactivation;
D O I
10.1016/S0304-4165(03)00028-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A chemically generated mutant of Staphylococcus aureus RN4220, GC6668, was isolated that had a fourfold increase in resistance to vancomycin. This phenotype reverted back to susceptibility by insertional mutagenesis with Tn917. In a selected set of revertants, Tn917 insertion was mapped to a unique chromosomal region upstream of mprF, a recently described gene that determines staphylococcal resistance to several host defense peptides. The genetic linkage between the vancomycin susceptibility and Tn917 insertion was then confirmed by transduction backcrosses into both GC6668 and GISA isolates, MER-S 12 and HT2002 0127. Northern blot analysis, insertional inactivation and complementation experiments showed that mprF mediates vancomycin susceptibility in S. aureus. The inactivation of mprF by Tn917 insertion in HT2002 0127 caused a significant increase in the binding of vancomycin to the cell membranes. This observation serves as a likely mechanism of the increased vancomycin susceptibility associated with mprF inactivation. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:117 / 121
页数:5
相关论文
共 21 条
[1]   Teicoplanin stress-selected mutations increasing σB activity in Staphylococcus aureus [J].
Bischoff, M ;
Berger-Bächi, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1714-1720
[2]   Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative [J].
Bobin-Dubreux, S ;
Reverdy, ME ;
Nervi, C ;
Rougier, M ;
Bolmström, A ;
Vandenesch, F ;
Etienne, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :349-352
[3]   Inactivation of a novel three-cistronic operon tcaR-tcaA-tcaB increases teicoplanin resistance in Staphylococcus aureus [J].
Brandenberger, M ;
Tschierske, M ;
Giachino, P ;
Wada, A ;
Berger-Bächi, B .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2000, 1523 (2-3) :135-139
[4]   Regulation of protein A synthesis by the sar and agr loci of Staphylococcus aureus [J].
Cheung, AL ;
Eberhardt, K ;
Heinrichs, JH .
INFECTION AND IMMUNITY, 1997, 65 (06) :2243-2249
[5]   Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50 [J].
Cui, LZ ;
Murakami, H ;
Kuwahara-Arai, K ;
Hanaki, H ;
Hiramatsu, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2276-2285
[6]   DETERMINATION OF VANCOMYCIN RELATED SUBSTANCES BY GRADIENT HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
INMAN, EL .
JOURNAL OF CHROMATOGRAPHY, 1987, 410 (02) :363-372
[7]   EMERGENCE OF TEICOPLANIN RESISTANCE DURING THERAPY OF STAPHYLOCOCCUS-AUREUS ENDOCARDITIS [J].
KAATZ, GW ;
SEO, SM ;
DORMAN, NJ ;
LERNER, SA .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (01) :103-108
[8]   Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method [J].
Kuroda, M ;
Kuwahara-Arai, K ;
Hiramatsu, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) :485-490
[9]  
MAHMOOD R, 1990, J BIOL CHEM, V265, P4652
[10]  
NOVICK RP, 1991, METHOD ENZYMOL, V204, P587